2015 Jury Panel
Professor Chris J. Packard CBE, Ph.D., FRCPath, D.Sc., FRCP(Gla), FRSE, Director of Research
and Development of the NHS Greater Glasgow & Clyde (NHSGGC), Honorary Professor of Vascular Biochemistry at the University of Glasgow, Scotland, UK. Additionally, he works as a Consultant Clinical Scientist at the Department of Biochemistry, NHS Greater Glasgow & Clyde.
Over his career Professor Packard has focused on research into coronary heart disease, its causes, treatment and prevention. Particular interests have included cholesterol and lipoprotein metabolism and how it is affected by diets and drugs, also large scale clinical trials of lipid lowering agents such as statins.
More recently his field of research has widened to include investigations of emerging risk factors for coronary heart disease, and the consequences of social deprivation on health and wellbeing.
As one of the main investigators of the West of Scotland Coronary Prevention Study (WOSCOPS) and the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER), Professor Packard helped establish the evidence base for statin use in CHD prevention. These trials provided confidence that statins are beneficial in primary prevention and in older adults, and revealed a consistency of treatment effect that encouraged their widespread use and changed the practice of medicine worldwide.
Professor Packard was principal investigator of the Study Psychological, social and biological determinants of ill health (pSoBid), a multi-disciplinary epidemiological study of the psychosocial and biological determinants of ill health and premature CHD in the east end of Glasgow. It revealed that factors such as adverse circumstances in childhood and personality traits were associated with ill-health and reduced wellbeing in adults living in deprived communities.
Professor Packard is a member of the Scottish government Life Sciences Advisory Board (LiSAB) and a number of other government committees. As one of the four NHS Research Scotland R&D Directors that form the NRS Strategy Board, he works with the Chief Scientist Office to set the framework for clinical research in Scotland.
Outside the laboratory, Professor Packard is active in local and national initiatives to promote health and wealth gains from medical research. He was founding chairman of NEXXUS, the West of Scotland Bioscience Network, which promoted community building and knowledge exchange between life sciences industry, academia and the NHS. Currently, he is representing the NHS in a Glasgow City Council led initiative to promote economic growth in the life sciences sector and co-development opportunities between the Health Board and industry. He was appointed Commander of the Order of the British Empire (CBE) in June 2014.